KẾT QUẢ ĐIỀU TRỊ THIẾU MÁU BẰNG ERYTHROPOIETIN ALPHA KẾT HỢP TRUYỀN SẮT TRÊN BỆNH NHÂN BỆNH THẬN MẠN CHƯA ĐIỀU TRỊ THAY THẾ TẠI BỆNH VIỆN ĐA KHOA TỈNH BẮC NINH

Abstract

Objective: Evaluate results of anemia treatment using erythropoietin alpha plus intravenous iron in chronic kidney patient without kidney replacement therapy at Bac Ninh provicne general hospital in 2023. Methodology: Cross-sectional descriptive study with longitudinal follow-up enrolled 30 chronic kidney patients. The patient was administrated erythropoietin alpha plus intravenous iron for treatinng anemia and followed up 1 month and 2 months. The study implemented  from 01/09/2022 to 30/09/2023 at Nephrology and Urology department, Bac Ninh provicne general hospital. Results: At first month of follow up, the proportion of patients increased Hb ≥ 1g/dl per month was 26,7%. At second month of follow up, the proportion was higher 30,0% compared to the first month.  After 2 month of treatment, the proportion of patients increased Hb ≥ 2g/dl per month was 26,7%. After 1 month and 2 month follow- up have 30% patients who achieved treatment target. Conclusion: anemia treatment using erythropoietin alpha plus intravenous iron in chronic kidney patient  might be effective in increasing Hb after one month and two month of treatment.